海普瑞(09989.HK)獲歐洲藥品管理局發藥品GMP證書

阿斯達克財經

2025/02/14

海普瑞(09989.HK) 公布，已於近日收到波蘭衛生監督機構(Chief Pharmaceutical Inspector)根據歐洲藥品管理局(「EMA」)相關規定發出的「藥品GMP證書」，認證產品為PFS1-PFS3灌裝生產線、PFSP1-PFSP4包裝線，認證產品是依諾肝素鈉預灌注射液。公司指，海普瑞坪山園區的新建預灌封製劑生產線項目去年已完成並首次通過歐盟GMP認證。根據歐盟成員國之間的...

網頁鏈接

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2511545626"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2511545626\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2511545626?lang=zh_TW&edition=fundamental","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210324165850406_s.jpg","is_english":false,"pubTime":"2025-02-14 16:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2511545626","market":"hk","top_or_hot":-1,"title":"海普瑞(09989.HK)獲歐洲藥品管理局發藥品GMP證書","media":"阿斯達克財經","content":"<div>\n<p>海普瑞(09989.HK) 公布，已於近日收到波蘭衛生監督機構(Chief Pharmaceutical Inspector)根據歐洲藥品管理局(「EMA」)相關規定發出的「藥品GMP證書」，認證產品為PFS1-PFS3灌裝生產線、PFSP1-PFSP4包裝線，認證產品是依諾肝素鈉預灌注射液。公司指，海普瑞坪山園區的新建預灌封製劑生產線項目去年已完成並首次通過歐盟GMP認證。根據歐盟成員國之間的...</p>\n\n<a href=\"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1417462/latest-news/AAFN\">網頁鏈接</a>\n\n</div>\n","source":"aastocks_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>海普瑞(09989.HK)獲歐洲藥品管理局發藥品GMP證書</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n海普瑞(09989.HK)獲歐洲藥品管理局發藥品GMP證書\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">阿斯達克財經</strong><span class=\"h-time small\">2025-02-14 16:52</span>\n</p>\n</h4>\n</header>\n<article>\n<div>\n<p>海普瑞(09989.HK) 公布，已於近日收到波蘭衛生監督機構(Chief Pharmaceutical Inspector)根據歐洲藥品管理局(「EMA」)相關規定發出的「藥品GMP證書」，認證產品為PFS1-PFS3灌裝生產線、PFSP1-PFSP4包裝線，認證產品是依諾肝素鈉預灌注射液。公司指，海普瑞坪山園區的新建預灌封製劑生產線項目去年已完成並首次通過歐盟GMP認證。根據歐盟成員國之間的...</p>\n\n<a href=\"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1417462/latest-news/AAFN\">網頁鏈接</a>\n\n</div>\n\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1417462/latest-news/AAFN\">阿斯達克財經</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"002399","symbol_name":"海普瑞","start_time":0,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1417462/latest-news/AAFN","article_id":"2511545626","we_media_id":null,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210324165850406_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1417462/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2511545626","pubTimestamp":1739523120,"columns":[],"sourceInfo":{"source_id":"aastocks_highlight","name":"阿思達克財經"},"weMediaInfo":null,"summary":"海普瑞(09989.HK) 公布，已於近日收到波蘭衞生監督機構(Chief Pharmaceutical Inspector)根據歐洲藥品管理局(「EMA」)相關規定發出的「藥品GMP證書」，認證產品為PFS1-PFS3灌裝生產線、PFSP1-PFSP4包裝線，認證產品是依諾肝素鈉預灌注射液。公司指，海普瑞坪山園區的新建預灌封製劑生產線項目去年已完成並首次通過歐盟GMP認證。根據歐盟成員國之間的GMP互認制度，本次通過GMP認證表明本次接受認證的生產線已符合歐盟GMP標準。(vc/da)(港股報價延遲最少十五分鐘。)AASTOCKS新聞","collect":0,"end_time":0,"defaultTopTitle":"aastocks.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"002399":"海普瑞","09989":"海普瑞","BK0239":"医药制造","BK1191":"制药","BK0188":"融资融券","BK0070":"员工持股"},"translate_title":"Hepalink (09989. HK) obtained a drug GMP certificate issued by the European Medicines Agency","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"002399":1,"09989":1},"content_text":"海普瑞(09989.HK) 公布，已於近日收到波蘭衞生監督機構(Chief Pharmaceutical Inspector)根據歐洲藥品管理局(「EMA」)相關規定發出的「藥品GMP證書」，認證產品為PFS1-PFS3灌裝生產線、PFSP1-PFSP4包裝線，認證產品是依諾肝素鈉預灌注射液。公司指，海普瑞坪山園區的新建預灌封製劑生產線項目去年已完成並首次通過歐盟GMP認證。根據歐盟成員國之間的GMP互認制度，本次通過GMP認證表明本次接受認證的生產線已符合歐盟GMP標準。(vc/da)(港股報價延遲最少十五分鐘。)AASTOCKS新聞","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}